In Partnership with AOL
  • News on INS-1 - Announcement that Insmed has discontinued its internal development of INS-1, one of its investigational drug candidates for type 2 diabetes and polycystic ovary syndrome (PCOS). (September 10, 2002)
    [!]
Volunteer to edit this category.
Copyright © 1998-2014 AOL Inc. Terms of Use
Visit our sister sites  mozilla.org | MusicMoz | Wikipedia

Last update: January 2, 2007 at 16:32:57 UTC - edit